FDA Clears Roche HER2 Tests to Expand Treatment Options in Metastatic Breast Cancer
Roche
Roche’s PATHWAY HER2 (4B5) test is the only test approved to identify all levels of HER2 expression
Articles by Roche
FDA Clears First TAGS-Powered Respiratory Panel for Simultaneous Detection of SARS-CoV-2, Flu, and RSV
Roche
Cleared for use on Roche’s cobas® systems, the new PCR test supports syndromic respiratory diagnostics with customizable panels and digital reflex capability
Roche Diagnostics Showcases AI, Digital Tools, and Clinical Innovation at ADLM 2025
Roche
At the ADLM 2025, Roche highlights advances in diagnostics, including digital health solutions, mass spectrometry, and expanded access to testing across care settings
Roche Receives FDA 510(k) Clearance for the First Blood Test in the US Measuring Lp(a) in Molar Units
Roche
The National Lipid Association recommends all adults measure their lipoprotein (a) at least once in a lifetime to help assess cardiovascular risk
Roche Showcases Solutions for Laboratories of the Future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo
Roche
Roche will present its growing portfolio of integrated systems and data solutions to optimize your resources and simplify and streamline your lab operations to drive better health outcomes
Roche Granted FDA Breakthrough Device Designation for Blood Test Measuring Lipoprotein (a)—a Key Marker for Hereditary Cardiovascular Risk
Roche
Lp(a), is emerging as an important, yet under-recognized, potential risk factor for cardiovascular disease, a major public health issue